elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34281123-6114EDB5-C58D-4A21-9B4C-437DEF3C8E69
Q34281123-6114EDB5-C58D-4A21-9B4C-437DEF3C8E69
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34281123-6114EDB5-C58D-4A21-9B4C-437DEF3C8E69
A new tubulin-binding site and pharmacophore for microtubule-destabilizing anticancer drugs
P2860
Q34281123-6114EDB5-C58D-4A21-9B4C-437DEF3C8E69
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34281123-6114EDB5-C58D-4A21-9B4C-437DEF3C8E69
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
30cfe1d602e80bad54db0c75a4f4cbcfb76b582f
P2860
Phase II clinical trials with rhizoxin in breast cancer and melanoma. The EORTC Early Clinical Trials Group.